Product Information
FONDAPARINUX 2.5 MG/0.5 ML SYR is a generic product labeled by Eugia US LLC, priced at $22.1623 per ML under NDC 55150023010. Its NADAC has been published 176 times since Mar 18, 2020.
FDA first approved this application on Dec 26, 2017. Its Orange Book therapeutic-equivalence code is AP.
Strength
2.5 mg/.5mL
Manufacturer
Eugia US LLCNDC
55150023010
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
8/19/2026
Active Ingredients
FONDAPARINUX SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA206918FDA Approved
12/26/2017
TE Code
AP
On Market Since
12/26/2017
Pharmacological Classes
Price Statistics
The NADAC for FONDAPARINUX 2.5 MG/0.5 ML SYR has been published 176 times since Mar 18, 2020, and over the history we have for it it has declined 45.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $22.1623 per ML |
|---|---|
| All-time high | $40.3736 (Mar 10, 2021) |
| All-time low | $18.9706 (Apr 22, 2026) |
| 52-week high | $26.4983 |
| 52-week low | $18.9706 |
| Median price | $27.0134 |
| Average price | $29.3998 |
| Largest weekly change | -39.2% (May 22, 2024) |
| Weeks tracked | 176 |
| Tracking since | Mar 18, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the FONDAPARINUX SODIUM market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Eugia US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
FONDAPARINUX SODIUM market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Factor Xa Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FONDAPARINUX 2.5 MG/0.5 ML SYR?
The current National Average Drug Acquisition Cost (NADAC) for FONDAPARINUX 2.5 MG/0.5 ML SYR, manufactured by Eugia US LLC, is $22.1623 per ML (NDC 55150023010), effective Sep 30, 2026.
How has the price of FONDAPARINUX 2.5 MG/0.5 ML SYR changed over time?
Over the history we have for it, the NADAC for FONDAPARINUX 2.5 MG/0.5 ML SYR has declined 45.1%. It has been tracked across 176 weekly CMS publications since Mar 18, 2020.
What are the highest and lowest recorded NADAC prices for FONDAPARINUX 2.5 MG/0.5 ML SYR?
Since Mar 18, 2020, the NADAC for FONDAPARINUX 2.5 MG/0.5 ML SYR has ranged from a low of $18.9706 (Apr 22, 2026) to a high of $40.3736 (Mar 10, 2021), with a median of $27.0134 per ML.
Are there cheaper alternatives to FONDAPARINUX 2.5 MG/0.5 ML SYR?
No other NADAC-published product currently shares the active ingredient and strength of FONDAPARINUX 2.5 MG/0.5 ML SYR in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FONDAPARINUX 2.5 MG/0.5 ML SYR?
FONDAPARINUX 2.5 MG/0.5 ML SYR (NDC 55150023010) is labeled by Eugia US LLC, and CMS classifies it as a generic product.